Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Qiagen (QGEN) EBT (2016 - 2025)

Qiagen's EBT history spans 17 years, with the latest figure at $109.2 million for Q4 2025.

  • On a quarterly basis, EBT fell 13.26% to $109.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $490.3 million, a 304.69% increase, with the full-year FY2025 number at $490.3 million, up 304.69% from a year prior.
  • EBT hit $109.2 million in Q4 2025 for Qiagen, down from $134.7 million in the prior quarter.
  • Over the last five years, EBT for QGEN hit a ceiling of $195.5 million in Q1 2022 and a floor of -$223.5 million in Q2 2024.
  • Historically, EBT has averaged $107.4 million across 5 years, with a median of $117.7 million in 2023.
  • Biggest five-year swings in EBT: soared 243.41% in 2021 and later plummeted 318.39% in 2024.
  • Tracing QGEN's EBT over 5 years: stood at $165.4 million in 2021, then crashed by 36.0% to $105.8 million in 2022, then increased by 12.32% to $118.9 million in 2023, then increased by 5.87% to $125.9 million in 2024, then decreased by 13.26% to $109.2 million in 2025.
  • Business Quant data shows EBT for QGEN at $109.2 million in Q4 2025, $134.7 million in Q3 2025, and $126.8 million in Q2 2025.